Suchbegriffe: NONSEMINOMA, . Treffer: 11
Dieckmann, KP; Pokrivcak, T; Geczi, L; Niehaus, D; Dralle-Filiz, I; Matthies, C; Dienes, T; Zschabitz, S; Paffenholz, P; Gschliesser, T; Pichler, R; Mego, M; Bader, P; Zengerling, F; Heinzelbecker, J; Krausewitz, P; Krege, S; Aurilio, G; Aksoy, C; Hentrich, M; Seidel, C; Torzsok, P; Nestler, T; Majewski, M; Hiester, A; Buchler, T; Vallet, S; Studentova, H; Schonburg, S; Niedersuss-Beke, D; Ring, J; Trenti, E; Heidenreich, A; Wulfing, C; Isbarn, H; Pichlmeier, U; Pichler, M
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
THER ADV MED ONCOL. 2022; 14: 17588359221086813
Doi: 10.1177/17588359221086813
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pratsinis, M; Fankhauser, C; Pratsinis, K; Beyer, J; Bührer, E; Cathomas, R; Fischer, N; Hermanns, T; Hirschi-Blickenstorfer, A; Kamradt, J; Alex, Kluth, L; Zihler, D; Mingrone, W; Müller, B; Nestler, T; Rothschild, SI; Seifert, B; Templeton, AJ; Terbuch, A; Ufen, MP; Woelky, R; Gillessen, S; Rothermundt, C
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Eur Urol Open Sci. 2022; 40: 16-18.
Doi: 10.1016/j.euros.2022.03.013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gillessen, S; Sauvé, N; Collette, L; Daugaard, G; de, Wit, R; Albany, C; Tryakin, A; Fizazi, K; Stahl, O; Gietema, JA; De, Giorgi, U; Cafferty, FH; Hansen, AR; Tandstad, T; Huddart, RA; Necchi, A; Sweeney, CJ; Garcia-Del-Muro, X; Heng, DYC; Lorch, A; Chovanec, M; Winquist, E; Grimison, P; Feldman, DR; Terbuch, A; Hentrich, M; Bokemeyer, C; Negaard, H; Fankhauser, C; Shamash, J; Vaughn, DJ; Sternberg, CN; Heidenreich, A; Beyer, J, , International, Germ, Cell, Cancer, Classification, Update, Consortium
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
J Clin Oncol. 2021; 39(14):1563-1574
Doi: 10.1200/JCO.20.03296
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fischer, S; Tandstad, T; Cohn-Cedermark, G; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, M; Langberg, CW; Ståhl, O; Fankhauser, CD; Hamid, AA; Koutsoukos, K; Shamash, J; White, J; Bokemeyer, C; Beyer, J; Gillessen, S, , Global, Germ-Cell, Cancer, Group
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol. 2020; 38(12):1322-1331
Doi: 10.1200/JCO.19.01876
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dieckmann, KP; Radtke, A; Geczi, L; Matthies, C; Anheuser, P; Eckardt, U; Sommer, J; Zengerling, F; Trenti, E; Pichler, R; Belz, H; Zastrow, S; Winter, A; Melchior, S; Hammel, J; Kranz, J; Bolten, M; Krege, S; Haben, B; Loidl, W; Ruf, CG; Heinzelbecker, J; Heidenreich, A; Cremers, JF; Oing, C; Hermanns, T; Fankhauser, CD; Gillessen, S; Reichegger, H; Cathomas, R; Pichler, M; Hentrich, M; Eredics, K; Lorch, A; Wülfing, C; Peine, S; Wosniok, W; Bokemeyer, C; Belge, G
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
J Clin Oncol. 2019; 37(16): 1412-1423.
Doi: 10.1200/JCO.18.01480
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Aufderklamm, S; Todenhöfer, T; Hennenlotter, J; Mischinger, J; Sim, A; Böttge, J; Rausch, S; Bier, S; Halalsheh, O; Stenzl, A; Gakis, G; Schwentner, C
Complex residual tumors after chemotherapy of nonseminomatous germ cell tumors. Laparoscopic management - limits and chances].
Urologe A. 2015; 54(7):1002-1009
Doi: 10.1007/s00120-014-3616-z
Web of Science
PubMed
FullText
FullText_MUG
Aufderklamm, S; Todenhöfer, T; Hennenlotter, J; Mischinger, J; Böttge, J; Rausch, S; Halalsheh, O; Stenzl, A; Gakis, G; Schwentner, C
Postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors infiltrating the great vessels.
J Endourol. 2014; 28(6):668-674
Doi: 10.1089/end.2013.0755
Web of Science
PubMed
FullText
FullText_MUG
Nastały, P; Ruf, C; Becker, P; Bednarz-Knoll, N; Stoupiec, M; Kavsur, R; Isbarn, H; Matthies, C; Wagner, W; Höppner, D; Fisch, M; Bokemeyer, C; Ahyai, S; Honecker, F; Riethdorf, S; Pantel, K
Circulating tumor cells in patients with testicular germ cell tumors.
Clin Cancer Res. 2014; 20(14):3830-41
Doi: 10.1158/1078-0432.CCR-13-2819
Web of Science
PubMed
FullText
FullText_MUG
Aufderklamm, S; Todenhöfer, T; Hennenlotter, J; Gakis, G; Mischinger, J; Mundhenk, J; Germann, M; Stenzl, A; Schwentner, C
Bilateral laparoscopic postchemotherapy retroperitoneal lymph-node dissection in nonseminomatous germ cell tumors--a comparison to template dissection.
J Endourol. 2013; 27(7):856-861
Doi: 10.1089/end.2012.0648
Web of Science
PubMed
FullText
FullText_MUG
Aufderklamm, S; Todenhöfer, T; Hennenlotter, J; Gakis, G; Mischinger, J; Mundhenk, J; Germann, M; Stenzl, A; Schwentner, C
Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity].
Urologe A. 2013; 52(8):1097-1103
Doi: 10.1007/s00120-013-3133-5
Web of Science
PubMed
FullText
FullText_MUG
Beyer, J; Kramar, A; Mandanas, R; Linkesch, W; Greinix, A; Droz, JP; Pico, JL; Diehl, A; Bokemeyer, C; Schmoll, HJ; Nichols, CR; Einhorn, LH; Siegert, W
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
J Clin Oncol. 1996; 14(10):2638-2645
Doi: 10.1200/JCO.1996.14.10.2638
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar